Cognitive impairment, including clinical Alzheimer’s-type dementia (CATD), mild cognitive impairment (MCI), or age-related cognitive decline (ARCD), affects a growing number of older adults. Given the impact of cognitive impairment on society, there is increasing interest on evidence-informed risk reduction of cognitive impairment.
In 2015, the National Institute on Aging (NIA) asked the National Academies of Sciences, Engineering, and Medicine (NASEM) to participate in a two-part project focused on examining the evidence of interventions for preventing, slowing, or delaying the onset of MCI and CATD, and delaying or slowing ARCD. The 2017 NASEM report, indicated that blood pressure management for people with hypertension can prevent, delay, or slow cognitive impairment, including ARCD, MCI, or CATD.
To respond to the recent evidence on risk reduction of cognitive decline, ACPM, with funding from Centers for Disease Control and Prevention has developed a continuing education module. This module is designed to improve healthcare providers’ awareness and ability to take action to utilize blood pressure control in middle-aged adults to reduce risk of cognitive impairment in later life.
Requires Payment